慢性血栓栓塞性肺动脉高压患者行球囊扩张成形术疗效分析

刘志煜; 曹昶; 陈熙; 徐若琛; 郑颖颖; 上官佳红; 唐俊楠; 张金盈

doi:10.16766/j.cnki.issn.1674-4152.003190

慢性血栓栓塞性肺动脉高压患者行球囊扩张成形术疗效分析

doi: 10.16766/j.cnki.issn.1674-4152.003190

刘志煜^{1, 2, 3},
曹昶^{1, 2, 3},
陈熙^{1, 2, 3},
徐若琛⁴,
郑颖颖^{1, 2, 3},
上官佳红^{1, 2, 3},
唐俊楠^{1, 2, 3},
张金盈^{1, 2, 3, ,}

1.
郑州大学第一附属医院心血管内科，河南郑州 450052
2.
河南省心脏损伤修复重点实验室，河南郑州 450052
3.
河南省心血管疾病临床医学研究中心，河南郑州 450052
4.
郑州大学基础医学院医学遗传与细胞生物学系，河南郑州 450001

基金项目:

国家自然科学基金项目 82000238

国家自然科学基金项目 81870328

河南省优秀青年科学基金项目 202300410362

详细信息

通讯作者:
张金盈，E-mail: jyzhang@zzu.edu.cn

中图分类号: R544.16
计量
- 文章访问数: 147
- HTML全文浏览量: 48
- PDF下载量: 27
- 被引次数: 0
出版历程
- 收稿日期: 2022-10-20
- 网络出版日期: 2023-11-23

Analysis of the treatment effect of percutaneous balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension

LIU Zhiyu^{1, 2, 3},
CAO Chang^{1, 2, 3},
CHEN Xi^{1, 2, 3},
XU Ruochen⁴,
ZHENG Yingying^{1, 2, 3},
SHANGGUAN Jiahong^{1, 2, 3},
TANG Junnan^{1, 2, 3},
ZHANG Jinying^{1, 2, 3
, ,}

1.
Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China

摘要

摘要: 目的评价球囊扩张成形术(BPA)治疗慢性血栓栓塞性肺动脉高压(CTEPH)的有效性和安全性。方法选择2019年10月—2022年6月郑州大学第一附属医院确诊CTEPH接受BPA手术的8例住院患者，收集患者的基本临床特征，观察BPA手术前后血流动力学指标、心脏结构改善情况及手术并发症事件的发生情况。结果女性患者5人，男性患者3人。发病时年龄为(55.25±10.45)岁，由急性肺栓塞进展至CTEPH形成时间为(10.87±6.10)个月，随访时长为(255.50±149.71)d，共进行BPA手术46次，出现咯血并发症1次发生于大动脉炎患者，平均BPA次数为(5.75±3.57)次。BPA术后肺动脉平均压由(92.25±33.59)mmHg(1 mmHg=0.133 kPa)降至(53.87±27.58)mmHg(P=0.022)；氨基末端脑钠肽前体、心输出量、心指数、三尖瓣反流速度、左心室舒张末期容积、纽约心脏病学会心功能分级均明显改善(均P < 0.05)。比较患者BPA手术前、出院前及随访时的心脏结构指标发现，右心室直径、左心室直径和右心房上下径均有改善(均P < 0.05)。结论 BPA手术作为一种新型手术方案，在CTEPH患者中应用后可改善血流动力学指标和心脏结构，同时并发症较少。
- 慢性血栓栓塞性肺动脉高压 /
- 球囊扩张成形术 /
- 急性肺栓塞
Abstract: Objective To evaluate the efficacy and safety of balloon pulmonary angioplasty (BPA) in a cohort of patients with pulmonary hypertension due to chronic thrombotic and/or embolic disease (CTEPH). Methods From October 2019 to June 2022, 8 patients diagnosed with CTEPH at the First Affiliated Hospital of Zhengzhou University underwent BPA surgery. The basic clinical characteristics of the patients were collected, and the hemodynamic indexes, improvement of cardiac structure, and surgical complications were observed. Results There were 5 female and 3 male patients. The mean age at presentation was (55.25±10.45) years, and the mean progressed period of CTEPH was (10.87±6.10) months, and the average follow-up duration was (255.50±149.71) days. A total of 46 BPA operations were performed, with one hemoptysis complication occurred in a patient with Takayasu' s arteritis, and the average number of BPA operations was (5.75±3.57) times. Mean pulmonary artery pressure after BPA decreased from (92.25±33.59) mmHg (1 mmHg=0.133 kPa) to (53.87±27.58) mmHg (P=0.022). NT-proBNP, cardiac output, cardiac index, tricuspid regurgitation velocity, EDV and NYHA were significantly improved (all P < 0.05). When cardiac structural parameters were compared before BPA surgery, before discharge and at follow-up, right ventricular diameter, left ventricular diameter, and right atrial upper and lower diameter were all improved (all P < 0.05). Conclusion BPA is a new surgical technique that can improve hemodynamic indexes and cardiac structure in CTEPH patients with fewer complications.
- Pulmonary hypertension due to chronic thrombotic and/or embolic disease /
- Balloon pulmonary angioplasty /
- Acute pulmonary embolism

HTML全文

图 1 CTEPH患者BPA手术前后肺动脉造影对比

注：A为动脉造影提示右肺中动脉分支开口血流闭塞；B为球囊至病变处扩张；C为造影提示狭窄明显减轻，前向血流3级。

Figure 1. Comparison of pulmonary angiography in CTEPH patients before and after BPA Surgery

下载: 全尺寸图片幻灯片

表 1 8例CTEPH患者行BPA前一般临床资料

Table 1. General clinical characteristics of 8 patients with CTEPH prior to BPA

编号	年龄(岁)	性别	CTEPH进展时程(月)	合并症	PAH药物治疗方案	BPA次数	择期手术次数	随访时长(d)
1	52	女性	10	中度三尖瓣关闭不全	安立生坦，西地那非	3	1	217
2	40	女性	5	左下肢静脉血栓	安立生坦，利奥西呱	2	1	198
3	62	男性	12	3级高血压，肺气肿	安立生坦，利奥西呱	8	3	271
4	66	男性	11	重度三尖瓣关闭不全，冠心病	贝前列素那，安立生坦，西地那非	7	2	31
5	68	女性	12	冠心病支架术后，3级高血压，糖尿病	安立生坦，利奥西呱	9	3	207
6	44	女性	24	大动脉炎，右肾动脉狭窄支架术后，甲状腺功能亢进症	西地那非	5	3	301
7	61	男性	9	心房颤动，下肢静脉曲张	利奥西呱	11	4	252
8	49	女性	4	下肢静脉血栓，中度三尖瓣关闭不全	未使用PAH药物治疗方案	1	1	566
注：编号6患者出现一次手术失败情况。

下载: 导出CSV

表 2 8例CTEPH患者BPA手术前和出院前血流动力学指标比较

Table 2. Comparison of hemodynamic parameters before and at discharge in 8 patients with CTEPH undergoing BPA

项目	手术前	出院前	统计量	P值
肺动脉平均压(x±s, mmHg)	92.25±33.59	53.87±27.58	3.620^a	0.022
NT-proBNP[M(P₂₅, P₇₅), pg/mL]	5 300.72(1 136.15，5 685.00)	377.29(74.98，946.00)	-2.201^b	0.028
心输出量(x±s, L/min)	4.60±1.71	5.88±1.99	-2.923^a	0.027
心指数[x±s, L/(min·m²)]	2.79±1.13	3.51±1.23	-3.013^a	0.024
肺动脉环径(x±s, mm)	24.28±3.09	23.57±3.20	0.420^a	0.689
三尖瓣反流速度(x±s, m/s)	4.41±0.93	3.22±0.93	4.095^a	0.005
EDV(x±s, mL)	66.57±26.96	89.71±24.28	-3.065^a	0.022
ESV(x±s, mL)	22.78±8.94	30.35±10.57	-2.177^a	0.072
LVEF(x±s, %)	64.37±4.47	66.00±5.63	-0.604^a	0.565
NYHA心功能分级(Ⅲ级/Ⅳ级，例)	0/8	6/2	5.143^c	0.016
注：^a为t值，^b为Z值，^c为χ²值。

下载: 导出CSV

表 3 8例CTEPH患者BPA手术前、出院前和随访时心脏结构测量结果比较(x±s，mm)

Table 3. Comparison of cardiac structural measurements before, at discharge, and during follow-up in 8 patients with CTEPH undergoing BPA (x±s, mm)

项目	手术前	出院前	随访时	F值	P值
右心室直径	26.42±7.43	20.75±4.83	18.57±6.39	5.982	0.016
左心室直径	38.57±4.99	43.37±4.62	42.00±4.72	8.013	0.028
右心房左右径	46.14±9.70	38.12±7.56	37.14±6.64	1.914	0.241
右心房上下径	57.71±8.97	49.12±8.77	47.00±10.47	6.191	0.014

下载: 导出CSV

参考文献(20)

[1]	PAPAMATHEAKIS D G, POCH D S, FERNANDES T M, et al. Chronic thromboembolic pulmonary hypertension: JACC focus seminar[J]. J Am Coll Cardiol, 2020, 76(18): 2155-2169. doi: 10.1016/j.jacc.2020.08.074
[2]	朱林, 卢冉, 郭飞. 多层螺旋CT多参数对急性肺动脉栓塞危险分层的效果评估[J]. 中华全科医学, 2021, 19(12): 2093-2097. doi: 10.16766/j.cnki.issn.1674-4152.002245 ZHU L, LU R, GUO F. Assessment of the effectiveness of multi-slice spiral CT multiparameter for risk stratification of acute pulmonary embolism[J]. Chinese Journal of General Practice, 2021, 19(12): 2093-2097. doi: 10.16766/j.cnki.issn.1674-4152.002245
[3]	POCH D, MANDEL J. Pulmonary hypertension[J]. Ann Intern Med, 2021, 174(4): ITC49-ITC64. DOI: 10.7326/AITC202104200.
[4]	王颖, 王孝高, 宋涛, 等. 肺动脉栓塞合并急性下肢深静脉血栓形成的类型比例分析与解读[J]. 中华全科医学, 2018, 16(1): 107-109. doi: 10.16766/j.cnki.issn.1674-4152.000031 WANG Y, WANG X G, SONG T, et al. Analysis and interpretation of the type of pulmonary embolism complicated with deep venous thrombosis of the lower extremities[J]. Chinese Journal of General Practice, 2018, 16(1): 107-109. doi: 10.16766/j.cnki.issn.1674-4152.000031
[5]	HUMBERT M, KOVACS G, HOEPER M M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Eur Heart J, 2022, 43(38): 3618-3731. doi: 10.1093/eurheartj/ehac237
[6]	GALIÈ N, HUMBERT M, VACHIERY J L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)[J]. Eur Heart J, 2016, 37(1): 67-119. doi: 10.1093/eurheartj/ehv317
[7]	GHOFRANI H A, KIM N H. Medical and interventional therapies for inoperable CTEPH: a necessary combination?[J]. Lancet Respir Med, 2022, 10(10): 926-927. doi: 10.1016/S2213-2600(22)00227-2
[8]	丁媛, 龚娟妮, 王剑锋, 等. 肺动脉球囊扩张成形术治疗慢性血栓栓塞性肺动脉高压的疗效观察[J]. 中华结核和呼吸杂志, 2020, 43(12): 1049-1054. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYI201912012.htm DING Y, GONG J N, WANG J F, et al. A retrospective study of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2020, 43(12): 1049-1054. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYI201912012.htm
[9]	赵智慧, 王勇, 罗勤, 等. 球囊肺动脉成形术治疗慢性血栓栓塞性肺动脉高压的安全性和有效性分析[J]. 中国循环杂志, 2019, 34(6): 563-567. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH202307010.htm ZHANG Z H, WANG Y, LUO Q, et al. Safety and efficacy of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension[J]. Chinese Circulation Journal, 2019, 34(6): 563-567. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH202307010.htm
[10]	中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组, 等. 中国肺动脉高压诊断与治疗指南(2021版)[J]. 中华医学杂志, 2021, 101(1): 11-51. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202303020.htm Pulmonary embolism and pulmonary vascular diseases group of Chinese Thoracic Society, Chinese Association of Chest Physicians pulmonary embolism and pulmonary vascular disease working committee, National pulmonary embolism and pulmonary vascular disease Prevention and Treatment Cooperation group, et al. Chinese Guidelines for the Diagnosis and Treatment of Pulmonary Artery Hypertension (2021 Edition)[J]. National Medical Journal of China, 2021, 101(1): 11-51. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202303020.htm
[11]	INAMI T, KATAOKA M, SHIMURA N, et al. Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty[J]. JACC Cardiovasc Interv, 2013, 6(7): 725-736.
[12]	ZOPPELLARO G, BADAWY M R, SQUIZZATO A, et al. Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis[J]. Circ J, 2019, 83(8): 1660-1667.
[13]	赵丹, 龚娟妮, 唐小红, 等. 肺动脉球囊扩张成形术治疗慢性血栓栓塞性肺动脉高压患者的疗效及不良反应观察[J]. 中国医刊, 2019, 54(12): 1308-1311. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYI201912012.htm ZHAO D, GONG J N, TANG X H, et al. Observation on the therapeutic effect and adverse reactions of balloon pulmonary angioplasty treating patients with chronic thrombotic pulmonary hypertension[J]. Chinese Journal of Medicine, 2019, 54(12): 1308-1311. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYI201912012.htm
[14]	江莹, 岳雯静, 吴慧玲, 等. 肺动脉高压专科护士角色职责研究的范围综述[J]. 中国护理管理, 2023, 23(2): 241-246. https://www.cnki.com.cn/Article/CJFDTOTAL-GLHL202302017.htm JAING Y, YUE W J, WU H L, et al. Role development and role responsibilities of clinical nurse specialists in Pulmonary Hypertension: a scoping review[J]. Chinese Nursing Management, 2023, 23(2): 241-246. https://www.cnki.com.cn/Article/CJFDTOTAL-GLHL202302017.htm
[15]	EJIRI K, AKAGI S, ITO H. Woman in her 50s with pulmonary hypertension associated with Takayasu arteritis[J]. JAMA Cardiol, 2023, 8(8): 792.
[16]	EZZEDDINE F M, HURST P D, BOOKWALTER C A. Takayasu arteritis[J]. Mayo Clin Proc, 2023, 98(7): 1033-1034.
[17]	MAHMUD E, ANG L. Time to standardize definitions for the success and complications of balloon pulmonary angioplasty: a quality imperative[J]. JACC Cardiovasc Interv, 2023, 16(8): 984-985.
[18]	RIVERS-BOWERMAN M D, ZENER R, JABERI A, et al. Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: new horizons in the interventional management of pulmonary embolism[J]. Tech Vasc Interv Radiol, 2017, 20(3): 206-215.
[19]	JAIN N, SHEIKH M A, BAJAJ D, et al. Periprocedural complications with balloon pulmonary angioplasty: analysis of global studies[J]. JACC Cardiovasc Interv, 2023, 16(8): 976-983.
[20]	LANG I M, ANDREASSEN A K, ANDERSEN A, et al. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function[J]. Eur Heart J, 2023, 44(29): 2659-2671.